UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Global health crises are also information crises: A call to action

Journal of the American Society for Information Science and Technology, 2020-12, Vol.71 (12), p.1419-1423

2020

Volltextzugriff (PDF)

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study

Osteoarthritis and cartilage, 2017-10, Vol.25 (10), p.1598-1606

2017

Volltextzugriff (PDF)

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

Annals of the rheumatic diseases, 2014-01, Vol.73 (1), p.48-55

2014

Volltextzugriff (PDF)

Review of head-to-head study designs in rheumatoid arthritis

Seminars in arthritis and rheumatism, 2016-12, Vol.46 (3), p.279-285

2016

Volltextzugriff (PDF)

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.805-811

2009

Volltextzugriff (PDF)

Predicting the impact of scientific concepts using full-text features

Journal of the Association for Information Science and Technology, 2016-11, Vol.67 (11), p.2684-2696

2016

Volltextzugriff (PDF)

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

The New England journal of medicine, 1999-01, Vol.340 (4), p.253-259

1999

Volltextzugriff (PDF)

Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24‐Week Patient‐Reported Outcome Results of a Phase III, Multicenter Study

Arthritis care & research (2010), 2014-07, Vol.66 (7), p.1085-1092

2014

Volltextzugriff (PDF)

Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains

Journal of Bacteriology, 2002-10, Vol.184 (19), p.5479-5490

2002

Volltextzugriff (PDF)

FRI0092 LONG-TERM SAFETY AND EFFICACY OF SARILUMAB OVER 5 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS REFRACTORY TO TUMOR NECROSIS FACTOR INHIBITORS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.624-625

2020

Volltextzugriff (PDF)

FRI0122 EFFICACY AND PATIENT-REPORTED OUTCOME MEASURES FROM A TWO-PART MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL TRIAL OF REPOSITORY CORTICOTROPIN INJECTION FOR PERSISTENTLY ACTIVE RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.642-642

2020

Volltextzugriff (PDF)

SAT0106 LONG-TERM SAFETY AND EFFICACY OF SARILUMAB OVER 5 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH 1 OR >1 PRIOR TUMOR NECROSIS FACTOR INHIBITOR FAILURES

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.987-987

2020

Volltextzugriff (PDF)

Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study

Rheumatology (Oxford, England), 2012-12, Vol.51 (12), p.2204-2214

2012

Volltextzugriff (PDF)

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2006-08, Vol.65 (8), p.1006-1012

2006

Volltextzugriff (PDF)

The Sociotechnical Construction of Distrust during the Covid‐19 Pandemic

The Hastings Center report, 2023-09, Vol.53 (S2), p.S16-S21

Fleischmann, Kenneth R.

2023

Volltextzugriff (PDF)

POS0086 ANALYSIS OF DISEASE ACTIVITY MEASURES IN THE CONTEXT OF A METHOTREXATE WITHDRAWAL STUDY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB 11 MG ONCE DAILY + METHOTREXATE: POST HOC ANALYSIS OF DATA FROM ORAL SHIFT

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.251-251

2021

Volltextzugriff (PDF)

Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

Annals of the rheumatic diseases, 2008-03, Vol.67 (3), p.346-352

2008

Volltextzugriff (PDF)

Alignment of whole genomes

Nucleic acids research, 1999-06, Vol.27 (11), p.2369-2376

1999

Volltextzugriff (PDF)

Experimental observation of a fundamental length scale of waves in random media

Physical review letters, 2013-11, Vol.111 (18), p.183902-183902, Article 183902

2013

Volltextzugriff (PDF)

Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

Annals of the rheumatic diseases, 2014-01, Vol.73 (1), p.233-237

2014

Volltextzugriff (PDF)

Community response grids: E-government, social networks, and effective emergency management

Telecommunications policy, 2007-11, Vol.31 (10), p.592-604

2007

Volltextzugriff (PDF)

POS0653 IMPACT OF UPADACITINIB OR ADALIMUMAB AS INITIAL THERAPY ON THE ACHIEVEMENT OF 48-WEEK TREATMENT GOALS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: POST HOC ANALYSIS OF A PHASE 3 STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.566-567

2021

Volltextzugriff (PDF)

Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison

Rheumatic & musculoskeletal diseases open, 2020-04, Vol.6 (1), p.e001131

2020

Volltextzugriff (PDF)

Older Adults’ Trust and Distrust in COVID-19 Public Health Information: Qualitative Critical Incident Study

JMIR aging, 2023-11, Vol.6, p.e42517-e42517

2023

Volltextzugriff (PDF)

POS0087 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 3 YEARS FROM THE SELECT-COMPARE STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.251-252

2021

Volltextzugriff (PDF)

1 – 25 von 2.114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.680)
Mit Volltextzugriff
(1.665)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(988)
Life Sciences & Biomedicine
(592)
Humans
(466)
Physical Sciences
(306)
Biological And Medical Sciences
(271)
Female
(263)
Male
(242)
Physics
(221)
Animals
(199)
Medical Sciences
(192)
Technology
(190)
Middle Aged
(181)
Adult
(149)
Mice
(123)
Aged
(121)
Exact Sciences And Technology
(105)
Rheumatology
(97)
Treatment Outcome
(92)
Rheumatoid Arthritis
(91)
Fundamental And Applied Biological Sciences. Psychology
(86)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Global health crises are also information crises: A call to action

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

Review of head-to-head study designs in rheumatoid arthritis

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

Predicting the impact of scientific concepts using full-text features

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24‐Week Patient‐Reported Outcome Results of a Phase III, Multicenter Study

Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains

FRI0092 LONG-TERM SAFETY AND EFFICACY OF SARILUMAB OVER 5 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS REFRACTORY TO TUMOR NECROSIS FACTOR INHIBITORS

FRI0122 EFFICACY AND PATIENT-REPORTED OUTCOME MEASURES FROM A TWO-PART MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL TRIAL OF REPOSITORY CORTICOTROPIN INJECTION FOR PERSISTENTLY ACTIVE RHEUMATOID ARTHRITIS

SAT0106 LONG-TERM SAFETY AND EFFICACY OF SARILUMAB OVER 5 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH 1 OR >1 PRIOR TUMOR NECROSIS FACTOR INHIBITOR FAILURES

Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

The Sociotechnical Construction of Distrust during the Covid‐19 Pandemic

POS0086 ANALYSIS OF DISEASE ACTIVITY MEASURES IN THE CONTEXT OF A METHOTREXATE WITHDRAWAL STUDY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB 11 MG ONCE DAILY + METHOTREXATE: POST HOC ANALYSIS OF DATA FROM ORAL SHIFT

Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

Alignment of whole genomes

Experimental observation of a fundamental length scale of waves in random media

Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

Community response grids: E-government, social networks, and effective emergency management

POS0653 IMPACT OF UPADACITINIB OR ADALIMUMAB AS INITIAL THERAPY ON THE ACHIEVEMENT OF 48-WEEK TREATMENT GOALS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: POST HOC ANALYSIS OF A PHASE 3 STUDY

Older Adults’ Trust and Distrust in COVID-19 Public Health Information: Qualitative Critical Incident Study

POS0087 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 3 YEARS FROM THE SELECT-COMPARE STUDY

Suchergebnisse filtern